Lam Research Corporation [NASDAQ: LRCX] jumped around 3.55 points on Tuesday, while shares priced at $384.96 at the close of the session, up 0.93%. The company report on August 4, 2020 that Lam Research and VELO3D Strike Strategic Agreement to Use Metal Additive Manufacturing Applications for Production of Semiconductor Capital Equipment.
Joint agreement includes proprietary process development and investment in VELO3D.
Digital manufacturing innovator VELO3D and Lam Research Corporation (Nasdaq: LRCX) today announced a joint development agreement that includes collaboration on novel materials and designs in metal additive manufacturing (AM) or 3D printing applications for the semiconductor industry. Lam plans to significantly increase the volume of parts produced by AM over the next five years.
Lam Research Corporation stock is now 31.66% up from its year-to-date (YTD) trading value. LRCX Stock saw the intraday high of $385.75 and lowest of $380.22 per share. The company’s 52-week high price is 387.70, which means current price is +112.24% above from all time high which was touched on 08/03/20.
Compared to the average trading volume of 1.98M shares, LRCX reached a trading volume of 1147689 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Lam Research Corporation [LRCX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LRCX shares is $395.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LRCX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Lam Research Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 30, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price from $270 to $435. The new note on the price target was released on July 21, 2020, representing the official price target for Lam Research Corporation stock. Previously, the target price had yet another raise to $305, while Stifel analysts kept a Hold rating on LRCX stock.
The Average True Range (ATR) for Lam Research Corporation is set at 11.70, with the Price to Sales ratio for LRCX stock in the period of the last 12 months amounting to 5.58. The Price to Book ratio for the last quarter was 12.33, with the Price to Cash per share for the same quarter was set at 37.02. Price to Free Cash Flow for LRCX in the course of the last twelve months was 33.37 with Quick ratio for the last quarter at 3.70.
How has LRCX stock performed recently?
Lam Research Corporation [LRCX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.33. With this latest performance, LRCX shares gained by 14.93% in over the last four-week period, additionally plugging by 18.30% over the last 6 months – not to mention a rise of 98.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LRCX stock in for the last two-week period is set at 70.16, with the RSI for the last a single of trading hit 73.65, and the three-weeks RSI is set at 68.10 for Lam Research Corporation [LRCX]. The present Moving Average for the last 50 days of trading for this stock 321.86, while it was recorded at 376.58 for the last single week of trading, and 286.93 for the last 200 days.
Lam Research Corporation [LRCX]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Lam Research Corporation [LRCX] shares currently have an operating margin of +26.62 and a Gross Margin at +45.88. Lam Research Corporation’s Net Margin is presently recorded at +22.42.
Return on Equity for this stock inclined to 45.74, with Return on Assets sitting at 16.96.
Lam Research Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 4.50.
Earnings analysis for Lam Research Corporation [LRCX]
With the latest financial reports released by the company, Lam Research Corporation posted 3.18/share EPS, while the average EPS was predicted by analysts to be reported at 3.01/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 5.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LRCX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lam Research Corporation go to 17.23%.
Insider trade positions for Lam Research Corporation [LRCX]
There are presently around $48,167 million, or 89.30% of LRCX stock, in the hands of institutional investors. The top three institutional holders of LRCX stocks are: BLACKROCK INC. with ownership of 12,655,695, which is approximately 1.186% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 12,089,253 shares of the stock with an approximate value of $4.65 billion in LRCX stocks shares; and FMR LLC, currently with $3.18 billion in LRCX stock with ownership of nearly -2.15% of the company’s market capitalization.
486 institutional holders increased their position in Lam Research Corporation [NASDAQ:LRCX] by around 13,163,598 shares. Additionally, 518 investors decreased positions by around 13,512,762 shares, while 113 investors held positions by with 98,444,612 shares. The mentioned changes placed institutional holdings at 125,120,972 shares, according to the latest SEC report filing. LRCX stock had 141 new institutional investments in for a total of 2,283,217 shares, while 109 institutional investors sold positions of 1,281,440 shares during the same period.